Bioneer Corporation (KOSDAQ:064550)
13,930
-440 (-3.06%)
Nov 7, 2025, 3:30 PM KST
Bioneer Revenue
Bioneer had revenue of 88.28B KRW in the quarter ending June 30, 2025, with 12.54% growth. This brings the company's revenue in the last twelve months to 298.51B, up 1.01% year-over-year. In the year 2024, Bioneer had annual revenue of 293.98B with 11.68% growth.
Revenue (ttm)
298.51B
Revenue Growth
+1.01%
P/S Ratio
1.20
Revenue / Employee
791.80M
Employees
377
Market Cap
359.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 293.98B | 30.74B | 11.68% |
| Dec 31, 2023 | 263.24B | 44.84B | 20.53% |
| Dec 31, 2022 | 218.39B | -5.35B | -2.39% |
| Dec 31, 2021 | 223.74B | 16.76B | 8.10% |
| Dec 31, 2020 | 206.99B | 170.70B | 470.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |